{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:57:14Z","timestamp":1722031034576},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010481","name":"Etablissement Fran\u00e7ais du Sang","doi-asserted-by":"crossref","award":["#2013-03-Douay-IDF"],"award-info":[{"award-number":["#2013-03-Douay-IDF"]}],"id":[{"id":"10.13039\/501100010481","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association pour la Recherche en Transfusion"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpharm.2017.06.073","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T08:16:18Z","timestamp":1498119378000},"page":"65-74","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide"],"prefix":"10.1016","volume":"529","author":[{"given":"Benjamin","family":"Caulier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Berthoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hel\u00e8ne","family":"Coradin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Garban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Claire","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Polack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Luc","family":"Lenormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Laurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.06.073_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1566523211313020002","article-title":"Technological overview of iPS induction from human adult somatic cells","volume":"13","author":"Bayart","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijpharm.2016.09.081","article-title":"Targeted release of transcription factors for cell reprogramming by a natural micro-syringe","volume":"513","author":"Berthoin","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrg3473","article-title":"Mechanisms and models of somatic cell reprogramming","volume":"14","author":"Buganim","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.stem.2011.11.003","article-title":"Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells","volume":"9","author":"Carey","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-X","article-title":"Expression of a single transfected cDNA converts fibroblasts to myoblasts","volume":"51","author":"Davis","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0040","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ng.428","article-title":"Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells","volume":"41","author":"Eminli","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0045","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/ph5111177","article-title":"Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges","volume":"5","author":"Erazo-Oliveras","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.stem.2009.09.008","article-title":"Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2","volume":"5","author":"Giorgetti","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","article-title":"Direct reprogramming of human fibroblasts to functional and expandable hepatocytes","volume":"14","author":"Huang","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nbt1418","article-title":"Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0065","doi-asserted-by":"crossref","first-page":"e0131128","DOI":"10.1371\/journal.pone.0131128","article-title":"Effects of integrating and non-integrating reprogramming methods on copy number variation and genomic stability of human induced pluripotent stem cells","volume":"10","author":"Kang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0075","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/nm951","article-title":"In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein","volume":"9","author":"Krosl","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymthe.2005.03.010","article-title":"Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction","volume":"12","author":"Kwon","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0085","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cell.2012.09.034","article-title":"Activation of innate immunity is required for efficient nuclear reprogramming","volume":"151","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2010.04.014","article-title":"A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts","volume":"7","author":"Li","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1387\/ijdb.140007XL","article-title":"Generation of pluripotent stem cells via protein transduction","volume":"58","author":"Li","year":"2014","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ncb2765","article-title":"Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT\u2013MET mechanism for optimal reprogramming","volume":"15","author":"Liu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/biot.201300505","article-title":"ZEBRA cell-penetrating peptide as an efficient delivery system in Candida albicans","volume":"9","author":"Marchione","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0110","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1038\/mtm.2014.56","article-title":"MD11-mediated delivery of recombinant eIF3f induces melanoma and colorectal carcinoma cell death","volume":"2","author":"Marchione","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0115","first-page":"1","article-title":"Study on the internalization mechanism of the ZEBRA cell-penetrating peptide","volume":"5","author":"Marchione","year":"2016","journal-title":"J. Mol. Biochem."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/ten.tec.2013.0026","article-title":"Generation of mouse induced pluripotent stem cells by protein transduction","volume":"20","author":"Nemes","year":"2014","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0135","first-page":"32","article-title":"The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders","volume":"6","author":"Papadopoulou","year":"2013","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0140","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1074\/jbc.M110.101550","article-title":"Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator","volume":"285","author":"Rothe","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tcb.2015.08.006","article-title":"Nuclear reprogramming by defined factors: quantity versus quality","volume":"26","author":"Sebban","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0150","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/eji.201546196","article-title":"FOXN1 recombinant protein enhances T-cell regeneration after hematopoietic stem cell transplantation in mice","volume":"46","author":"Song","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature19764","article-title":"In vitro and ex vivo strategies for intracellular delivery","volume":"538","author":"Stewart","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0160","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00018-010-0347-1","article-title":"Transcription factor-based modulation of neural stem cell differentiation using direct protein transduction","volume":"67","author":"Stock","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature09591","article-title":"Direct conversion of human fibroblasts to multilineage blood progenitors","volume":"468","author":"Szabo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0175","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1387\/ijdb.103193mt","article-title":"Exploring refined conditions for reprogramming cells by recombinant Oct4 protein","volume":"54","author":"Thier","year":"2010","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0180","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0185","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2017.06.073_bib0190","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.biomaterials.2012.03.061","article-title":"Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:51:52Z","timestamp":1589763112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317305811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0378517317305811"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.073","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}